The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)

Purpose The impact of SARS-CoV-2 pandemic on other pathogens is largely unknown. We aimed to compare the prevalence of vaccine-preventable invasive bacterial infections before and during the pandemic in Piedmont (Italy). Methods We defined the monthly incidence of S. pneumoniae , H. influenzae and N...

Full description

Saved in:
Bibliographic Details
Published in:Infection 2022-06, Vol.50 (3), p.767-770
Main Authors: Peradotto, Marco, Bondi, A., Lombardi, D., Bottino, P., Zanotto, E., Barbui, A. M., Cavallo, R.
Format: Article
Language:English
Subjects:
Bacteria
Bacterial diseases
Brief Report
COVID-19
Epidemiology
Family Medicine
General Practice
Infectious Diseases
Internal Medicine
Medicine
Medicine & Public Health
Pandemics
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Streptococcus infections
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-a49dd2b356754a71810e2644e026dadfb8a77364fea5c576947cf72307a31b273
cites cdi_FETCH-LOGICAL-c474t-a49dd2b356754a71810e2644e026dadfb8a77364fea5c576947cf72307a31b273
container_end_page 770
container_issue 3
container_start_page 767
container_title Infection
container_volume 50
creator Peradotto, Marco
Bondi, A.
Lombardi, D.
Bottino, P.
Zanotto, E.
Barbui, A. M.
Cavallo, R.
description Purpose The impact of SARS-CoV-2 pandemic on other pathogens is largely unknown. We aimed to compare the prevalence of vaccine-preventable invasive bacterial infections before and during the pandemic in Piedmont (Italy). Methods We defined the monthly incidence of S. pneumoniae , H. influenzae and N. meningitides -invasive diseases from January 2010 to June 2021. Then, we compared the mean monthly cases during the previous 5 years (2015–2019) and the monthly cases in 2020 or 2021. Results We found significant reductions for invasive pneumococcal diseases (IPDs) in adults and H. influenzae -invasive diseases in 2020 and 2021 in comparison to the previous years, but not for invasive meningococcal diseases and IPDs in children. Conclusions Further data are needed to confirm these findings and define possible post-pandemic evolutions in the epidemiology of vaccine-preventable invasive bacterial diseases.
doi_str_mv 10.1007/s15010-022-01770-6
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8852962</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2671455569</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-a49dd2b356754a71810e2644e026dadfb8a77364fea5c576947cf72307a31b273</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EotPCH2CBLLEpC8P1O9kgoYHCSJXKorC1HMdpXSV2sDOR-u9xmVIeC1ZenO8e33MPQi8ovKEA-m2hEigQYIwA1RqIeoQ2VPCWQKv5Y7QBDkAaytQROi7lBgBkK_RTdMQl1VRIsUHx8trjMM3WLTgNeHvxbfeB0BbPNvZ-Cg67FJecRpwiXq1zIXoyZ7_6uNhurKNxtSWsHnfVwedgR9yH4m3xpWr4S_D9VB3w6W6x4-3rZ-jJYMfin9-_J-jr2cfL7WdyfvFpt31_TpzQYiFWtH3POi6VlsJq2lDwTAnhgane9kPXWK25EoO30kmtaio3aMZBW047pvkJenfwnffd5HtX1812NHMOk823Jtlg_lZiuDZXaTVNI1mrWDU4vTfI6fvel8VMoTg_jjb6tC-GKdbyRnKgFX31D3qT9jnWeJW6O7OUqq0UO1Aup1KyHx6WoWDu6jSHOk2t0_ys06g69PLPGA8jv_qrAD8ApUrxyufff__H9gfO46qV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2671455569</pqid></control><display><type>article</type><title>The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)</title><source>Springer Nature</source><creator>Peradotto, Marco ; Bondi, A. ; Lombardi, D. ; Bottino, P. ; Zanotto, E. ; Barbui, A. M. ; Cavallo, R.</creator><creatorcontrib>Peradotto, Marco ; Bondi, A. ; Lombardi, D. ; Bottino, P. ; Zanotto, E. ; Barbui, A. M. ; Cavallo, R.</creatorcontrib><description>Purpose The impact of SARS-CoV-2 pandemic on other pathogens is largely unknown. We aimed to compare the prevalence of vaccine-preventable invasive bacterial infections before and during the pandemic in Piedmont (Italy). Methods We defined the monthly incidence of S. pneumoniae , H. influenzae and N. meningitides -invasive diseases from January 2010 to June 2021. Then, we compared the mean monthly cases during the previous 5 years (2015–2019) and the monthly cases in 2020 or 2021. Results We found significant reductions for invasive pneumococcal diseases (IPDs) in adults and H. influenzae -invasive diseases in 2020 and 2021 in comparison to the previous years, but not for invasive meningococcal diseases and IPDs in children. Conclusions Further data are needed to confirm these findings and define possible post-pandemic evolutions in the epidemiology of vaccine-preventable invasive bacterial diseases.</description><identifier>ISSN: 0300-8126</identifier><identifier>EISSN: 1439-0973</identifier><identifier>DOI: 10.1007/s15010-022-01770-6</identifier><identifier>PMID: 35171454</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Bacteria ; Bacterial diseases ; Brief Report ; COVID-19 ; Epidemiology ; Family Medicine ; General Practice ; Infectious Diseases ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Pandemics ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Streptococcus infections ; Vaccines</subject><ispartof>Infection, 2022-06, Vol.50 (3), p.767-770</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-a49dd2b356754a71810e2644e026dadfb8a77364fea5c576947cf72307a31b273</citedby><cites>FETCH-LOGICAL-c474t-a49dd2b356754a71810e2644e026dadfb8a77364fea5c576947cf72307a31b273</cites><orcidid>0000-0001-6236-1010</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35171454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peradotto, Marco</creatorcontrib><creatorcontrib>Bondi, A.</creatorcontrib><creatorcontrib>Lombardi, D.</creatorcontrib><creatorcontrib>Bottino, P.</creatorcontrib><creatorcontrib>Zanotto, E.</creatorcontrib><creatorcontrib>Barbui, A. M.</creatorcontrib><creatorcontrib>Cavallo, R.</creatorcontrib><title>The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)</title><title>Infection</title><addtitle>Infection</addtitle><addtitle>Infection</addtitle><description>Purpose The impact of SARS-CoV-2 pandemic on other pathogens is largely unknown. We aimed to compare the prevalence of vaccine-preventable invasive bacterial infections before and during the pandemic in Piedmont (Italy). Methods We defined the monthly incidence of S. pneumoniae , H. influenzae and N. meningitides -invasive diseases from January 2010 to June 2021. Then, we compared the mean monthly cases during the previous 5 years (2015–2019) and the monthly cases in 2020 or 2021. Results We found significant reductions for invasive pneumococcal diseases (IPDs) in adults and H. influenzae -invasive diseases in 2020 and 2021 in comparison to the previous years, but not for invasive meningococcal diseases and IPDs in children. Conclusions Further data are needed to confirm these findings and define possible post-pandemic evolutions in the epidemiology of vaccine-preventable invasive bacterial diseases.</description><subject>Bacteria</subject><subject>Bacterial diseases</subject><subject>Brief Report</subject><subject>COVID-19</subject><subject>Epidemiology</subject><subject>Family Medicine</subject><subject>General Practice</subject><subject>Infectious Diseases</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Pandemics</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Streptococcus infections</subject><subject>Vaccines</subject><issn>0300-8126</issn><issn>1439-0973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUtv1DAUhS0EotPCH2CBLLEpC8P1O9kgoYHCSJXKorC1HMdpXSV2sDOR-u9xmVIeC1ZenO8e33MPQi8ovKEA-m2hEigQYIwA1RqIeoQ2VPCWQKv5Y7QBDkAaytQROi7lBgBkK_RTdMQl1VRIsUHx8trjMM3WLTgNeHvxbfeB0BbPNvZ-Cg67FJecRpwiXq1zIXoyZ7_6uNhurKNxtSWsHnfVwedgR9yH4m3xpWr4S_D9VB3w6W6x4-3rZ-jJYMfin9-_J-jr2cfL7WdyfvFpt31_TpzQYiFWtH3POi6VlsJq2lDwTAnhgane9kPXWK25EoO30kmtaio3aMZBW047pvkJenfwnffd5HtX1812NHMOk823Jtlg_lZiuDZXaTVNI1mrWDU4vTfI6fvel8VMoTg_jjb6tC-GKdbyRnKgFX31D3qT9jnWeJW6O7OUqq0UO1Aup1KyHx6WoWDu6jSHOk2t0_ys06g69PLPGA8jv_qrAD8ApUrxyufff__H9gfO46qV</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Peradotto, Marco</creator><creator>Bondi, A.</creator><creator>Lombardi, D.</creator><creator>Bottino, P.</creator><creator>Zanotto, E.</creator><creator>Barbui, A. M.</creator><creator>Cavallo, R.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6236-1010</orcidid></search><sort><creationdate>20220601</creationdate><title>The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)</title><author>Peradotto, Marco ; Bondi, A. ; Lombardi, D. ; Bottino, P. ; Zanotto, E. ; Barbui, A. M. ; Cavallo, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-a49dd2b356754a71810e2644e026dadfb8a77364fea5c576947cf72307a31b273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bacteria</topic><topic>Bacterial diseases</topic><topic>Brief Report</topic><topic>COVID-19</topic><topic>Epidemiology</topic><topic>Family Medicine</topic><topic>General Practice</topic><topic>Infectious Diseases</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Pandemics</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Streptococcus infections</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peradotto, Marco</creatorcontrib><creatorcontrib>Bondi, A.</creatorcontrib><creatorcontrib>Lombardi, D.</creatorcontrib><creatorcontrib>Bottino, P.</creatorcontrib><creatorcontrib>Zanotto, E.</creatorcontrib><creatorcontrib>Barbui, A. M.</creatorcontrib><creatorcontrib>Cavallo, R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peradotto, Marco</au><au>Bondi, A.</au><au>Lombardi, D.</au><au>Bottino, P.</au><au>Zanotto, E.</au><au>Barbui, A. M.</au><au>Cavallo, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)</atitle><jtitle>Infection</jtitle><stitle>Infection</stitle><addtitle>Infection</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>50</volume><issue>3</issue><spage>767</spage><epage>770</epage><pages>767-770</pages><issn>0300-8126</issn><eissn>1439-0973</eissn><abstract>Purpose The impact of SARS-CoV-2 pandemic on other pathogens is largely unknown. We aimed to compare the prevalence of vaccine-preventable invasive bacterial infections before and during the pandemic in Piedmont (Italy). Methods We defined the monthly incidence of S. pneumoniae , H. influenzae and N. meningitides -invasive diseases from January 2010 to June 2021. Then, we compared the mean monthly cases during the previous 5 years (2015–2019) and the monthly cases in 2020 or 2021. Results We found significant reductions for invasive pneumococcal diseases (IPDs) in adults and H. influenzae -invasive diseases in 2020 and 2021 in comparison to the previous years, but not for invasive meningococcal diseases and IPDs in children. Conclusions Further data are needed to confirm these findings and define possible post-pandemic evolutions in the epidemiology of vaccine-preventable invasive bacterial diseases.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>35171454</pmid><doi>10.1007/s15010-022-01770-6</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-6236-1010</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0300-8126
ispartof Infection, 2022-06, Vol.50 (3), p.767-770
issn 0300-8126
1439-0973
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8852962
source Springer Nature
subjects Bacteria
Bacterial diseases
Brief Report
COVID-19
Epidemiology
Family Medicine
General Practice
Infectious Diseases
Internal Medicine
Medicine
Medicine & Public Health
Pandemics
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Streptococcus infections
Vaccines
title The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A01%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20COVID-19%20pandemic%20control%20on%20vaccine-preventable%20invasive%20bacterial%20diseases%20in%20Piedmont%20(Italy)&rft.jtitle=Infection&rft.au=Peradotto,%20Marco&rft.date=2022-06-01&rft.volume=50&rft.issue=3&rft.spage=767&rft.epage=770&rft.pages=767-770&rft.issn=0300-8126&rft.eissn=1439-0973&rft_id=info:doi/10.1007/s15010-022-01770-6&rft_dat=%3Cproquest_pubme%3E2671455569%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-a49dd2b356754a71810e2644e026dadfb8a77364fea5c576947cf72307a31b273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2671455569&rft_id=info:pmid/35171454&rfr_iscdi=true